Initially, our results confirmed the expression of TLR5 in a human monocyte line (THP-1) and isolated human CD14+ monocytes (Mo) using flow cytometry (Figure 1b,c); in addition, the MDA-MB-231 breast cancer line was used as non-immune cell control. This evidence concerns the gene TLR5 and breast carcinoma.